<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037398</url>
  </required_header>
  <id_info>
    <org_study_id>A4063</org_study_id>
    <nct_id>NCT03037398</nct_id>
  </id_info>
  <brief_title>Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation</brief_title>
  <acronym>CLOVER</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the performance of novel DBS programming methods
      compared to traditional programming methods.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in time to program between the two arms at Programming Visit</measure>
    <time_frame>at least four months post implant</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Novel Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Programming completed by a novel method</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Programming completed as Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vercise Deep Brain Stimulation System</intervention_name>
    <arm_group_label>Novel Arm</arm_group_label>
    <arm_group_label>Standard of Care Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implanted bilaterally in STN with a Verciseâ„¢ DBS system for Parkinson's disease for at
             least six months and programming optimized according to standard of care with no
             changes to electrode configuration of primary settings for at least four weeks.

          -  Able to understand the study requirements and the treatment procedures and provides
             written informed consent before any study-specific tests or procedures are performed.

          -  Be at least 18 years of age.

        Exclusion Criteria:

          -  Any significant psychiatric problems, including unrelated clinically significant
             depression as determined by the investigator.

          -  Device must be implanted on label.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Neuromodulation Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Keesey</last_name>
    <phone>661-949-4175</phone>
    <email>diane.keesey@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshini Jain</last_name>
    <phone>469-766-9888</phone>
    <email>roshini.jain@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research Toll-Free Number</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>91355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 12, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

